Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Multi-Omics & Data Reporting Services
Are you currently facing complex challenges in pre-clinical research, difficulty in translating findings from animal models to human trials, or challenges in identifying new drug targets? Our NHP Multi-Omics & Data Reporting Services help you accelerate drug discovery and streamline translational research through advanced multi-omics integration and comprehensive data analysis. By harnessing the power of NHP models, we provide a holistic view of biological systems, from brain aging to immune responses, delivering the actionable insights you need to move your projects forward.
Overview of NHP Multi-Omics Services
NHPs are the gold standard for translational research due to their remarkable genetic, anatomical, and physiological similarities to humans. Their use allows for the study of complex diseases in a controlled, biologically relevant environment. At Creative Biolabs, we leverage this advantage to provide you with an unparalleled understanding of disease mechanisms and therapeutic responses.
What Our Service Is
Our service provides a comprehensive, multi-omics approach to biological research. We move beyond single-layer analysis to integrate multiple datasets, revealing the interconnected molecular changes that govern health and disease.
- Proteomics & Metabolomics Pipelines: We offer robust, high-resolution pipelines that analyze the complete set of proteins and metabolites within a sample. This provides a functional snapshot of cellular activity and helps identify key biomarkers and pathways.
- Integrated Bioinformatics Report: Our service goes beyond raw data. We provide a detailed, integrated report that combines genomics, proteomics, and metabolomics data to identify coordinated molecular pathways.
Our services are applicable to:
- Biomarker Identification: Pinpoint novel molecular markers for disease progression, prognosis, and therapeutic response.
- Pre-Clinical Drug Development: Validate drug targets and assess the efficacy and safety of new compounds.
- Disease Mechanism Research: Uncover the intricate molecular pathways underlying complex diseases, from neurodegeneration to immune-related disorders.
Why Choose Us?
Fragmented data and isolated research approaches create bottlenecks that stall progress. Creative Biolabs offers a seamless, end-to-end solution that transforms scattered data into actionable insights.
-
Pain Point: Your research is limited by a single "omics" layer, providing an incomplete picture of biological processes.
- Benefit: Our integrated multi-omics approach provides a holistic view, revealing coordinated molecular changes that single analyses miss.
-
Pain Point: You struggle to find new, relevant therapeutic targets and biomarkers.
- Benefit: We identify both previously known and novel pathways, opening up new avenues for drug discovery and development.
Multi-dimensional immune cell atlas of rhesus macaque tissues.
Key Benefits of Our Service
Creative Biolabs provides a distinct advantage through our unique features and capabilities, grounded in our extensive experience with NHP models. We help you accelerate your research and development with confidence.
- Exceptional Response Speed: Our streamlined workflows and optimized data analysis pipelines ensure a rapid turnaround time for your projects, enabling you to make timely decisions.
- Extensive NHP Resources: We have access to a controlled, well-characterized cohort of NHPs. This controlled environment ensures high-quality data and eliminates variables that can confound results.
- Customization: We offer a flexible, modular service that can be tailored to the specific needs of your project, from target discovery to pre-clinical validation.
- Reporting Depth: Our comprehensive reports provide a deep dive into your data, including detailed annotations, pathway analysis, and a clear summary of key findings.
How Creative Biolabs' Services Can Assist Your Project?
Our service provides a clear and predictable path from sample to actionable insights, ensuring you can make informed decisions at every stage of your project.
01
Project Consultation & Planning
02
Sample Preparation & Quality Control
03
Multi-Omics Data Generation
04
Integrated Bioinformatics Analysis
05
Scientific Reporting & Interpretation
06
Final Deliverables
Key Deliverables
Our service delivers a comprehensive suite of resources to empower your research, including:
- Comprehensive Lab Report outlining methods and findings.
- Raw and processed data files from all omics layers.
- Integrated bioinformatics reports with pathway analysis and data visualizations.
- Model annotations and cell type classification where applicable.
- Publication-quality figures and data summaries for reports and presentations.
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: How can multi-omics on non-human primates directly benefit my human drug development program?
A: NHPs provide a bridge between basic research and human clinical trials due to their close genetic and physiological similarities. By conducting multi-omics studies in NHPs, we can identify drug targets and biomarkers with high translational potential, significantly increasing the likelihood of success in human trials.
Q: I already have some genomics data. Can you integrate it with new proteomics and metabolomics data?
A: Absolutely. Our services are designed to be flexible. We can seamlessly integrate existing datasets with new data generated from our proteomics and metabolomics pipelines. This approach maximizes the value of your existing research and provides a more holistic view.
Q: What kind of sample is required to start a project, and how is the data reported?
A: We can work with a variety of sample types, including tissues, cell lines, and purified biomolecules. We provide a detailed and intuitive report that not only contains the raw data but also provides an integrated bioinformatics analysis, making it easy to understand the key findings and their implications.
Q: How do your services compare to other providers?
A: Our key differentiator is our deep expertise in NHP research combined with a comprehensive, integrated multi-omics platform. We offer a more nuanced approach than providers who only offer single-omic services, allowing for a systems-level understanding that is critical for translational research.
Q: The timeframe seems long. What factors influence the duration?
A: While we pride ourselves on efficiency, the 6-12 weeks timeframe ensures meticulous quality control at every stage. The duration is primarily influenced by the number of samples and the complexity of the analysis required. We can provide a more precise estimate during a project consultation.
Contact Us
Creative Biolabs' NHP Multi-Omics & Data Reporting Services provide a revolutionary approach to translational research. We empower you to move beyond fragmented insights by offering a holistic, multi-omics view of biological systems. Through our advanced pipelines, rigorous analysis, and integrated reporting, we help you accelerate drug discovery and identify critical biomarkers. To learn how a partnership with Creative Biolabs can transform your research and lead to your next breakthrough, contact our specialists today.
Reference
- Staupe, Ryan P., et al. "Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells." Communications Biology 5.1 (2022): 1399, Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s42003-022-04216-9